vesnarinone has been researched along with Autoimmune Diseases in 2 studies
Autoimmune Diseases: Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myocarditis was induced in 30 Lewis rats by injection of porcine cardiac myosin and vesnarinone was orally administered to 20 of the 30 rats." | 7.70 | Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats. ( Hiroe, M; Hosokawa, T; Ikeda, I; Ishiyama, S; Kasajima, T; Marumo, F; Nishikawa, T; Shimojo, T; Toyozaki, T, 1999) |
| "Myocarditis was induced in 30 Lewis rats by injection of porcine cardiac myosin and vesnarinone was orally administered to 20 of the 30 rats." | 3.70 | Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats. ( Hiroe, M; Hosokawa, T; Ikeda, I; Ishiyama, S; Kasajima, T; Marumo, F; Nishikawa, T; Shimojo, T; Toyozaki, T, 1999) |
| "Vesnarinone is an experimental drug which is known to inhibit TNF alpha release." | 1.30 | Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injury. ( Baumann, H; Jacob, CO; Kambayashi, T; Lazarus, DD; Strassmann, G; Yato-Kioka, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lazarus, DD | 1 |
| Kambayashi, T | 1 |
| Yato-Kioka, M | 1 |
| Baumann, H | 1 |
| Jacob, CO | 1 |
| Strassmann, G | 1 |
| Ishiyama, S | 1 |
| Hiroe, M | 1 |
| Nishikawa, T | 1 |
| Shimojo, T | 1 |
| Hosokawa, T | 1 |
| Ikeda, I | 1 |
| Toyozaki, T | 1 |
| Kasajima, T | 1 |
| Marumo, F | 1 |
2 other studies available for vesnarinone and Autoimmune Diseases
| Article | Year |
|---|---|
Vesnarinone inhibits immune-mediated but not Fas (CD95) agonist-mediated hepatic injury.
Topics: Acute-Phase Reaction; Animals; Antibodies, Monoclonal; Autoimmune Diseases; Chemical and Drug Induce | 1997 |
Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats.
Topics: Analysis of Variance; Animals; Autoimmune Diseases; Biomarkers; Blotting, Northern; Female; Interleu | 1999 |